Multinationals Return To Growth In China In First Half

New Drugs More Than Offset VBP Impact

 
• By Brian Yang and Dexter Jie Yan
  
Poring Studio/Shutterstock.com
Multinational drug makers return to growth in first half of 2023
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia